Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$40.32 - $50.97 $174,343 - $220,394
-4,324 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$41.72 - $51.34 $9,136 - $11,243
-219 Reduced 4.82%
4,324 $201,000
Q3 2020

Nov 13, 2020

BUY
$37.02 - $51.28 $27,431 - $37,998
741 Added 19.49%
4,543 $193,000
Q2 2020

Aug 14, 2020

BUY
$43.24 - $55.02 $12,020 - $15,295
278 Added 7.89%
3,802 $182,000
Q4 2019

Feb 19, 2020

BUY
$54.32 - $64.31 $4,888 - $5,787
90 Added 2.62%
3,524 $212,000
Q3 2019

Nov 05, 2019

SELL
$53.25 - $59.98 $266 - $299
-5 Reduced 0.15%
3,434 $194,000
Q2 2019

Aug 12, 2019

BUY
$46.61 - $58.45 $6,059 - $7,598
130 Added 3.93%
3,439 $191,000
Q1 2019

May 07, 2019

SELL
$38.66 - $51.82 $4,097 - $5,492
-106 Reduced 3.1%
3,309 $167,000
Q4 2018

Feb 13, 2019

BUY
$36.72 - $67.73 $4,186 - $7,721
114 Added 3.45%
3,415 $138,000
Q3 2018

Nov 13, 2018

BUY
$66.65 - $83.86 $59,851 - $75,306
898 Added 37.37%
3,301 $229,000
Q2 2018

Aug 14, 2018

BUY
$51.25 - $76.62 $4,356 - $6,512
85 Added 3.67%
2,403 $182,000
Q1 2018

May 14, 2018

BUY
$52.16 - $66.86 $7,563 - $9,694
145 Added 6.67%
2,318 $122,000
Q4 2017

Feb 14, 2018

BUY
$49.6 - $60.87 $644 - $791
13 Added 0.6%
2,173 $116,000
Q3 2017

Nov 13, 2017

BUY
$46.62 - $60.36 $100,699 - $130,377
2,160
2,160 $129,000

Others Institutions Holding EGRX

About EAGLE PHARMACEUTICALS, INC.


  • Ticker EGRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,015,900
  • Market Cap $6.77M
  • Description
  • Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...
More about EGRX
Track This Portfolio

Track Mason Street Advisors, LLC Portfolio

Follow Mason Street Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mason Street Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mason Street Advisors, LLC with notifications on news.